Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I know but you'd be surprised how they let their guard down on emails sometimes. The FCA don't really care about AIM. Still there's more than one way to do most things. Let's see if we get some TR1's once the fairly vague timeframe of admittance to trading is up, if not doesn't look good for Walbrook. They've already p155ed off about a million ODX holders including some fairly respectable ones. Only so far they can hide behind bent rules.
Genedrive got a mention in a Russian publication last week in the list of TOP key players in the TB Infection Testing Market Report. Nice to have a mention with the like of Danaher, Roche, Qiagen and some other fairly massice players.
http://zaryabryansk.com/2021/10/14/????????????-????????-????????????-5/
Even if forward selling is legal, still not sure it is, Walbrook actively telling everyone there is no placing is not legal if there is one. If it was forward sold then clearly the answer should have been yes, a fundraising is coming, rather than cut and paste cut and paste fk off' and read a circular.
Still showing as pre-qualified on the sysmex website.
https://www.sysmex-ap.com/product/genedrive-hcv-id-kit/
Director holdings have been updated. Other 23m still unaccounted for? So either multiple buyers all under 3% (think it only took 4 hours to fill so unlikely) or someone is illegally hiding. Walbrok fail to clarify... as usual.
A medical body in Africa has thoroughly reviewed and scrutinised the Genedrive HCV test against the Abbot test of all rivals! Came up well. This happened on Monday which could explain the 10% rise we saw then.
https://t.co/Qx4ZYbJSqh?amp=1
It's when sentiment and morale is this low the big money is made on a sudden delivery on AIM. I'd think there would be a genuine all look at each other, did that really happen, pause before such a delivery would sink in here tho lol.
LFT market is a bit of a farce anyway. Yes we need a universal test but the innova one gave accuracy consistent with a coin toss. Agree on AIHL. If you look past GDR's involvement and focus more on the deficit this will address, the NIHR interest and the people who are involved/following then it looks really good. Again no press right up on it. A few medical journalists plugging this nationally/globally will have substantial reach do more than a sales team. Question is why isn't that happening?
$3000 so about £2200. Then you have a device you can use anywhere, office, school, hotels, airports, train stations, cinema etc with accurate 10 min results for a positive result. Would also appear to mobile testing companies that want to get involved with onsite testing.
POC effectively replaces LFT's and traditional PCR. Quicker, more convenient and localised. Timing is perfect on this one if they can launch it on time and properly.
New forms for EUA submission on the FDA website. No idea if GDR and Beckman are re-applying through this new system for their products still waiting on EUA (will they go back to the front of the queue?) and Walbrook, as usual, have failed to clarify - prob way over their head.
Thouse who said Fincap are pulling numbers out of the air seem right. Again WalbrookPR said read the circular for more info. No info there on the question asked - as usual.